Clinical Trial Update: A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports on LY3437943 in postmenopausal women who are overweight or obese; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3437943

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight | Phase 1 | Status: COMPLETED